Evidence map›Paper›PMID 26173930›Full record

ArticleHuman mutation2015

GeneMatcher aids in the identification of a new malformation syndrome with intellectual disability, unique facial dysmorphisms, and skeletal and connective tissue abnormalities caused by de novo variants in HNRNPK.

P Y Billie Au, Jing You, Oana Caluseriu, Jeremy Schwartzentruber, Jacek Majewski, Francois P Bernier, Marcia Ferguson, Care for Rare Canada Consortium, David Valle, Jillian S Parboosingh and 3 more

Abstract readCase Reports
In one paragraph

Article in Human mutation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Case Report: A novelFrontiers in psychiatry · 2026
    Article
  5. Expert consensus on classification and diagnosis of congenital orofacial cleft.Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2025
    Article
  6. Article
  7. Prenatal diagnosis of aFrontiers in genetics · 2025
    Article
  8. Genetic and Phenotypic Spectrum ofDiagnostics (Basel, Switzerland) · 2024
    Article
  9. Hnrnpk protects against osteoarthritis through targeting WWC1 mRNA and inhibiting Hippo signaling pathway.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

P Y Billie Au *Department of Medical Genetics, University of Calgary, Cumming School of Medicine, Alberta, Canada.
Jing You *Predoctoral Training Program in Human Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Oana CaluseriuDepartment of Medical Genetics, University of Alberta, Edmonton, Alberta, Canada.
Jeremy SchwartzentruberDepartment of Human Genetics, McGill and Genome Quebec Innovation Center, McGill University, Quebec, Canada.
Jacek MajewskiDepartment of Human Genetics, McGill and Genome Quebec Innovation Center, McGill University, Quebec, Canada.
Francois P BernierDepartment of Medical Genetics, University of Calgary, Cumming School of Medicine, Alberta, Canada.
Marcia FergusonHarvey Institute for Human Genetics, Department of Pediatrics, Greater Baltimore Medical Center, Baltimore, MD.
Care for Rare Canada Consortium
David ValleMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Jillian S ParboosinghDepartment of Medical Genetics, University of Calgary, Cumming School of Medicine, Alberta, Canada.
Nara SobreiraMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
A Micheil Innes *Department of Medical Genetics, University of Calgary, Cumming School of Medicine, Alberta, Canada.
Antonie D Kline *Harvey Institute for Human Genetics, Department of Pediatrics, Greater Baltimore Medical Center, Baltimore, MD.

Funding

Baylor-Johns Hopkins Center for Mendelian GeneticsU54HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2012 to 2015
$15.6M
Canadian Institutes of Health ResearchNHGRI NIH HHS 1U54HG006542NHGRI NIH HHS U54 HG006542
6 · The paper itself

Abstract

We report a new syndrome due to loss-of-function variants in the heterogeneous nuclear ribonucleoprotein K gene (HNRNPK). We describe two probands: one with a de novo frameshift (NM_002140.3: c.953+1dup), and the other with a de novo splice donor site variant (NM_002140.3: c.257G>A). Both probands have intellectual disability, a shared unique craniofacial phenotype, and connective tissue and skeletal abnormalities. The identification of this syndrome was made possible by a new online tool, GeneMatcher, which facilitates connections between clinicians and researchers based on shared interest in candidate genes. This report demonstrates that new Web-based approaches can be effective in helping investigators solve exome sequencing projects, and also highlights the newer paradigm of "reverse phenotyping," where characterization of syndromic features follows the identification of genetic variants.

Indexed as

Databases, GeneticPolymorphism, Single NucleotideAbnormalities, MultipleAdolescentChildCraniofacial AbnormalitiesGenetic Predisposition to DiseaseHeterogeneous-Nuclear Ribonucleoprotein KHumansInformation DisseminationIntellectual DisabilityMaleMuscular AtrophyPhenotypeRibonucleoproteinsSoftwareHeterogeneous-Nuclear Ribonucleoprotein KHNRNPK protein, humanRibonucleoproteinsGeneMatcherHNRNPKmatchmaker exchangereverse phenotypingWES

Identifiers

PMID26173930
PMCPMC4589226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.